Copyright
©The Author(s) 2023.
World J Radiol. Jan 28, 2023; 15(1): 20-31
Published online Jan 28, 2023. doi: 10.4329/wjr.v15.i1.20
Published online Jan 28, 2023. doi: 10.4329/wjr.v15.i1.20
Table 2 Numbers of benign and malignant salivary gland tumors
| Benign SGTs | n (%) | Malignant SGTs | n (%) |
| Warthin’s tumor | 18 (24.7) | Squamous cell carcinoma | 11 (15.1) |
| Pleomorphic adenoma | 14 (19.2) | Adenoid cystic carcinoma | 3 (4.1) |
| Inflammatory process | 12 (16.4) | Malignant lymphoma | 3 (4.1) |
| Lipoma | 4 (5.5) | Adenocarcinoma | 1 (1.4) |
| Benign cystic lesions | 1 (1.4) | Mucoepidermoid carcinoma | 1 (1.4) |
| Carcinoma ex pleomorphic adenoma | 1 (1.4) | ||
| Other benign lesions | 1 (1.4) | Acinic cell carcinoma | 1 (1.4) |
| Follicular dendritic cell sarcoma | 1 (1.4) | ||
| Salivary duct carcinoma | 1 (1.4) | ||
| Total | 50 (68.5) | 23 (31.5) |
- Citation: Gökçe E, Beyhan M. Diagnostic efficacy of diffusion-weighted imaging and semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging in salivary gland tumors. World J Radiol 2023; 15(1): 20-31
- URL: https://www.wjgnet.com/1949-8470/full/v15/i1/20.htm
- DOI: https://dx.doi.org/10.4329/wjr.v15.i1.20